Trimethobenzamide Hydrochloride
Sponsors
Pfizer
Conditions
HealthyIdiopathic Parkinson Disease
Phase 1
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy Subjects
CompletedNCT02262767
Start: 2014-11-30End: 2014-12-31Updated: 2015-01-14
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease
CompletedNCT02373072
Start: 2015-03-31End: 2016-03-31Updated: 2023-09-22